Mercodia

Mercodia is a Swedish life science company focused on immunoassays, biomarker analysis, and bioanalytical services for cardiometabolic disease research and drug development. The company operates as a specialized bioanalytical CRO supporting preclinical through clinical studies, particularly for biologics, biosimilars, peptides, and gene therapy products. Mercodia also develops, manufactures, and distributes proprietary ELISA and chemiluminescent assays used in research and clinical diagnostics, with strong expertise in diabetes, obesity, and related cardiorenal-metabolic conditions. In addition, it provides contract manufacturing and assay development services from facilities in Sweden and the United States. Rather than advancing its own therapeutic drug pipeline, Mercodia generates revenue through commercial products and fee-for-service scientific support for pharma, biotech, and academic customers.